Canada to approve Stargus Biofungicide

Health Canada's Pest Management Regulatory Agency (PMRA), under the authority of the Pest Control Products Act, is proposing registration for the sale and use of MBI-110 TGAI and Stargus Biofungicide (previously known as MBI-110 EP Biofungicide), containing the technical grade active ingredient Bacillus amyloliquefaciens strain F727, to partially suppress grey mould on indoor-grown cannabis and to suppress or partially suppress certain economically important diseases on field-grown hemp, grape, tomato, potato, red (garden) beet, sugar beet, cabbage and Brussels sprouts.

Bacillus amyloliquefaciens strain F727 is a bacterium used to manage certain plant diseases by reducing the establishment of causal pathogens, mycelial growth and spore germination.

Bacillus amyloliquefaciens strain F727 is currently registered for suppression or partial suppression of listed diseases on various terrestrial food crops. For details, see Proposed Registration Decision PRD2018-17, Bacillus amyloliquefaciens strain F727 and MBI-110 EP Biofungicide and Registration Decision RD2018-20, Bacillus amyloliquefaciens strain F727 and MBI-110 EP Biofungicide.

An evaluation of available scientific information found that, under the approved conditions of use, the health and environmental risks and the value of the pest control products are acceptable.

This consultation is open for comment from 25 October 2022 to 9 December 2022 (45 calendar days).